Cancer · 1992 · 56 citations · 27 references
MedicineCancer BiologyOncologyNeoplasiaNeuro-oncologyOncogenesBrain TumorsCentral Nervous System TumorsNeuro-oncologic PathologyTumor MarkersMyc Proto-oncogeneNeuroblastoma BiologyNeuropeptide SecretionOncogene Expression AnalysisPrimary Tumor AssessmentPrimary Tumor DetectionPrognostic Factors AnalysisVasoactive Intestinal Peptide Signaling
BACKGROUND: The neuropeptide contents in neuroblastomas were quantified by radioimmunoassay (RIA) to assess their possible biologic significance. METHODS: Neuroblastoma tumor tissue was obtained from the primary tumor site before therapy in 16 patients with newly diagnosed neuroblastoma and in 7 patients with central nervous system medulloblastomas or gliomas. RESULTS: The tumor tissue was assayed for vasoactive intestinal peptide (VIP), somatostatin (SRIF), substance P, and neurotensin by both immunostaining and RIA techniques. Increased VIP levels of 1.2 pg/micrograms DNA or more correlated significantly with cellular differentiation (P = 0.003) and favorable disease stage (P = 0.002) in neuroblastomas. Increased SRIF contents (greater than 1.3 pg/micrograms DNA) correlated with differentiation of the tumor (P = 0.002). Increased VIP and SRIF content did not correlate with N-myc oncogene expression or ras oncogene protein immunostaining. No VIP was detectable in brain tumors, and other neuropeptides were variable in content. CONCLUSIONS: RIA of VIP and SRIF levels in primary tumor tissue may offer an independent objective assay of biologic behavior in neuroblastoma biopsy specimens.
27
S M Hsu, Laurence Raine, Herbert Fanger · Journal of Histochemistry & Cytochemistry · 1981 · 14.3K citations · Full text
Hiroyuki Shimada, Jane Chatten, William A. Newton et al. · JNCI Journal of the National Cancer Institute · 1984 · 869 citations
Terry Smith · Trends in Pharmacological Sciences · 1982 · 418 citations
Prognostic factors in neuroblastoma
Audrey E. Evans, Giulio J. D’Angio, Kathleen J. Propert et al. · Cancer · 1987 · 321 citations · Full text
Medicine, Oncology, Metastasis +9